North America Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031

North America Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031

The North America Circulating Tumor Cell Market would witness market growth of 12.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Circulating Tumor Cell Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $6,117.7 million by 2031. The Canada market is experiencing a CAGR of 14.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 14% during (2024 - 2031).

Another key application of CTCs is in assessing the efficacy of cancer treatments. Traditional methods of evaluating treatment response, such as imaging and biopsies, can be invasive and may not provide immediate feedback.

Additionally, CTCs, on the other hand, allow for real-time monitoring of tumor behavior, offering insights into whether a treatment is working or if resistance is developing. This facilitates a more agile approach to oncology, enabling adjustments to the treatment plan before the cancer worsens.

The highest prevalence was observed in cancers such as breast, prostate, thyroid, colon, and cervical cancer. With this rising cancer burden, there is a growing need for more effective diagnostic and monitoring solutions. CTCs, a non-invasive method for detecting cancer cells circulating in the bloodstream, can revolutionize cancer diagnosis and treatment monitoring in Mexico. As the healthcare system in Mexico continues to improve and expand, the demand for advanced diagnostic tools like CTCs will grow, leading to increased market opportunities.

Based on Product, the market is segmented into Kits & Reagents, Devices, and Blood Collection Tubes. Based on End User, the market is segmented into Research and Academic Institutes, Hospital & Clinics, and Diagnostic Centers. Based on Specimen, the market is segmented into Blood, Bone Marrow, and Other Specimen. Based on Technology, the market is segmented into CTC Detection & Enrichment Methods, CTC Analysis, and CTC Direct Detection. Based on Application, the market is segmented into Research, Clinical, and Drug/Therapy Development. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Qiagen N.V
• Greiner Bio-One International GmbH
• Sysmex Corporation
• Miltenyi Biotech B.V & Co kg
• Bio-Techne Corporation
• Ikonisys, Inc.
• Menarini Silicon Biosystems SpA
• LungLife AI Inc.
• Aviva Systems Biology Corporation
• ScreenCell

North America Circulating Tumor Cell Market Report Segmentation

By Product

• Kits & Reagents
• Devices
• Blood Collection Tubes

By End User

• Research and Academic Institutes
• Hospital & Clinics
• Diagnostic Centers

By Specimen

• Blood
• Bone Marrow
• Other Specimen

By Technology

• CTC Detection & Enrichment Methods
• CTC Analysis
• CTC Direct Detection

By Application

• Research, Clinical
• Drug/Therapy Development

By Country

• US
• Canada
• Mexico
• Rest of North America